Phase 1 Solid Tumors trials recruiting now

All Solid Tumors trials, every phase

Other phases for Solid Tumors

Phase 1 Solid Tumors trials

• A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
  NCT06783569 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
  NCT06636435 · Phase: Phase 1 · Ages: 2 Years and older · Sex: All (male and female) · 5 locations
• A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
  NCT06873555 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
  NCT07274852 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
  NCT06179160 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 34 locations
• CTS2190 Phase I /II Clinical Study in Patients
  NCT06224387 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
  NCT05490472 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors
  NCT06621563 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
  NCT05024214 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 23 locations
• Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
  NCT05315700 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 42 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.